Skip to main content

Pluri Inc.

PLUR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001158780

No open-market purchases or sales by Pluri Inc. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $55.3K in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Pluri Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of PLUR: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders6159−2
Shares6.34M4.52M−1.82M (−28.7%)
Value$30.2M$17.9M−$12.3M (−40.8%)

New holders (14)

Institutions that held Pluri Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to PLUR in Q2 2021
InstitutionSharesValue% of portfolio
Gsa Capital Partners LLP159,731$633.0K0.07%
Walleye Capital LLC123,266$488.0K0.02%
Parallax Volatility Advisers, L.P.114,960$455.0K0.01%
SG3 Management, LLC57,543$228.0K0.10%
Green Alpha Advisors, LLC50,555$200.0K0.14%
D. E. Shaw & Co., Inc.43,917$174.0K0.00%
Caption Management, LLC40,000$158.0K0.01%
PDT Partners, LLC33,597$133.0K0.01%
Pathstone Family Office, LLC17,210$68.0K0.00%
Susquehanna International Group Ltd.13,902$55.0K0.02%
Susquehanna Fundamental Investments, LLC13,400$53.0K0.00%
Cowen and Company, LLC10,134$40.0K0.00%
BlackRock Inc.6,677$26.0K0.00%
US Bancorp500$2.00K0.00%

Sold out (16)

Institutions that held Pluri Inc. at the end of Q1 2021 and filed for Q2 2021 without it.